In her first ever run for office in 2018, Democratic Rep. Elaine Luria had a sharp diagnosis of what ailed U.S. policy making: the toxic influence of campaign contributions from powerful industries.
“There are many obstacles to cutting prescription drug costs, and I think that’s because the leadership in Congress who is there to vote on this and bring this legislation to the floor, they’re accepting thousands if not millions of dollars from prescription drug companies,” Luria said in a debate held shortly before the midterm elections. “A key tenet in my campaign is that I am not accepting any corporate PAC contributions. Not from prescription drug companies, not from oil companies, not from health care companies, not from private prisons, not from anyone who can influence my vote when I go to Washington.”
Read the full post at The Brick House Cooperative.